Related MeSH Hierarchy (12)
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Germ Cell and Embryonal » Neuroectodermal Tumors » Neuroendocrine Tumors » Neurilemmoma » Neuroma, Acoustic » Neurofibromatosis 2
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Nerve Sheath Neoplasms » Neurofibroma » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Otorhinolaryngologic Neoplasms » Neuroma, Acoustic » Neurofibromatosis 2
Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Cranial Nerve Neoplasms » Neuroma, Acoustic » Neurofibromatosis 2
Diseases [C] » Nervous System Diseases [C10] » Cranial Nerve Diseases » Vestibulocochlear Nerve Diseases » Neuroma, Acoustic » Neurofibromatosis 2
Diseases [C] » Nervous System Diseases [C10] » Neurocutaneous Syndromes » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Nervous System Diseases [C10] » Neurodegenerative Diseases » Heredodegenerative Disorders, Nervous System » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Heredodegenerative Disorders, Nervous System » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Neoplastic Syndromes, Hereditary » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Nerve Tissue » Nerve Sheath Neoplasms » Neuroma » Neurilemmoma » Neuroma, Acoustic » Neurofibromatosis 2
Diseases [C] » Neoplasms [C04] » Neoplastic Syndromes, Hereditary » Neurofibromatoses » Neurofibromatosis 2
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Ear Diseases » Retrocochlear Diseases » Vestibulocochlear Nerve Diseases » Neuroma, Acoustic » Neurofibromatosis 2
Description
An autosomal dominant disorder characterized by a high incidence of bilateral acoustic neuromas as well as schwannomas (NEURILEMMOMA) of other cranial and peripheral nerves, and other benign intracranial tumors including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the NF2 gene (GENES, NEUROFIBROMATOSIS 2) on chromosome 22 (22q12) and usually presents clinically in the first or second decade of life. MeSH
Hierarchy View
Phase 1 Indicated Drugs (3)
Organization Involved with Phase 2 Indications (22)
Organization Involved with Phase 1 Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
